Oncology

fake-news-misinformation-in-the-healthcare-medical-health-sector

Snippets - A Small piece of News or Article

Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization

Information and Communications Technology (ICT) over the past few years have changed the way of communication. Among all the communication mediums, social media, in particular, has got a lot of attention and offers a huge benefit over traditional media. It has empowered the common man to quickly and easily get access to a broad range of information, and express their personal experience, thoughts and views on the same. However, every coin has two faces. Amid a lot of benefits that social media provides, there are many negative aspects associated with it, which are hard to neglect. Privacy is one of the critical issues today. Recently “WhatsApp” (a messaging applicatio...

Explore More...

NgAgo gene-editing, claiming to be a better alternative to CRISPR gene editing, falls into a controversy in peer-reviewed papers

Sun Pharma & ICGEB announce collaboration; Boehringer Ingelheim and Lupin Sign deal; Daiichi Sankyo Announces; Catalent Pharma Solutions partners with Samsung Bioepis; Celltrion Healthcare and Teva enters into exclusive business collaboration agreement

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Oncology

Fake News In The Healthcare Sector: A Misinformation Crisis In The Era Of Digitalization

Most Common Cancers

CDC study reveals; Jevtana receives yes; Herantis secures; Immuno-oncology is not cost-effective

Novartis joins; Sanofi weighs Actelion; Valeant and Takeda’s $10B deal; Astellas scouts pipeline

Glaxo replaces ViiV; Lilly nets; AstraZeneca shuffles off; Gazyva aims to beat

The next generation of ‘weaponized antibody’ therapies

EC grants; Pfizer cuts; 27 medicines sold; Keytruda nabs

NgAgo gene-editing, claiming to be a better alternative to CRISPR gene editing, falls into a controversy in peer-reviewed papers

Novartis Buys; FDA approves; Mayne Pharma Launches; Oxford Genetics Receives Grant

More Views & Analysis

Phosphoinositide 3-Kinase (PI3k) Inhibitors: Emerging target therapies against Cancer

CRISPR gene-editing tested in a person for the first time

Aurobindo’s net profit; LLS selects; Eli Lilly secures; DNA vaccine against Zika

Collaborate for TYG Oncology; GE Healthcare and Valneva collaboration; UPS to Acquire Marken

Biosimilar Market in India

Boston Biomedical starts phase III; Martindale receives approval; Merck snagged yes; Nanotechnology to improve HIV

Sun Pharma & ICGEB announce collaboration; Boehringer Ingelheim and Lupin Sign deal; Daiichi Sankyo Announces; Catalent Pharma Solutions partners with Samsung Bioepis; Celltrion Healthcare and Teva enters into exclusive business collaboration agreement

Liquid Biopsy: Revolutionary Technique for Cancer Diagnosis

Subscribe to our Updates

Daily

Weekly

Monthly